MAPT and Alzheimer disease: As in AD, no significant difference was observed between the AD-designated patients and non-AD-designated patients in age, MMSE, Aβ, tau, phosphorylated tau (p > 0.075, student t-test), or APOE genotype (p > 0.3, chi-square), by either SVM methods.